Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy

Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy

Malignant pleural mesothelioma (MPM) is an aggressive malignancy with a severe prognosis, and with a long-standing need for more effective therapeutic approaches. However, treatment with immune checkpoint inhibitors is becoming an increasingly effective strategy for MPM patients. In this scenario, e...

Full description

Bibliographic Details
Main Authors: Maria Fortunata Lofiego, Sara Cannito, Carolina Fazio, Francesca Piazzini, Ornella Cutaia, Laura Solmonese, Francesco Marzani, Carla Chiarucci, Anna Maria Di Giacomo, Luana Calabrò, Sandra Coral, Michele Maio, Alessia Covre, on behalf of the EPigenetic Immune-Oncology Consortium Airc (EPICA) Investigators
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Epigenomes
Subjects:
epigenetic drugs
DNA methylation
immunotherapy
malignant pleural mesothelioma
Online Access:https://www.mdpi.com/2075-4655/5/4/27

Internet

https://www.mdpi.com/2075-4655/5/4/27

Similar Items